Neurologic Manifestations  >>  lisdexamfetamine  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lisdexamfetamine / Generic mfg.
NCT00807222: Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)

Completed
N/A
24
US
lisdexamfetamine dimesylate, Vyvanse
Clinical Study Centers, LLC, Shire
Attention Deficit Hyperactivity Disorder, Sleep
08/08
08/08
NCT00736255: Attention Deficit Hyperactivity Disorder (ADHD) Smoking Cessation Study

Completed
N/A
32
US
Transdermal Nicotine Patch, Nicotine Patch, Lis-dexamphetamine (Vyvanse), LDX and Transdermal Nicotine Patch, Placebo, Placebo and Transdermal Nicotine Patch
Duke University, Shire
Attention Deficit Hyperactivity Disorder, Nicotine Dependence
07/11
07/11
NCT01263548: To Evaluate the Safety and Metabolic Profile of Vyvanse for the Treatment of ADHD in Euthymic Adults With Bipolar I/II Disorder

Completed
N/A
45
Canada
lisdexamfetamine dimesylate, Vyvanse
University Health Network, Toronto, Shire
Attention Deficit/Hyperactivity Disorder, Bipolar Disorder
01/12
01/12

Download Options